Position in MRK
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$7,663,740
+$566,991 QoQ
Shares Held
59,640
+1.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#846
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pure Financial Advisors, LLC holds $38,114,911 across 13 Drug Manufacturers - General names. MRK ranks #2 (20.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,010 | $8,408,005 | |
| 2 | MRK |
Merck & Co., Inc.
This page
|
59,640 | $7,663,740 | |
| 3 | JNJ |
Johnson & Johnson
|
29,199 | $7,415,670 | |
| 4 | ABBV |
AbbVie Inc.
|
23,887 | $6,010,924 | |
| 5 | AMGN |
Amgen Inc
|
7,972 | $2,886,820 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
22,483 | $1,295,470 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,775 | $982,293 | |
| 8 | NVO |
Novo Nordisk A S
|
16,779 | $804,385 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,663,740 | 59,640 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $7,096,749 | 58,997 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $6,014,135 | 57,136 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $4,557,063 | 54,296 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $4,328,785 | 54,684 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $2,133,954 | 23,774 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $2,247,054 | 22,588 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $2,392,822 | 21,071 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $3,257,178 | 26,310 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $3,478,202 | 26,360 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $2,823,727 | 25,901 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $2,403,367 | 23,345 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $2,530,502 | 21,930 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $2,339,303 | 21,988 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $2,376,770 | 21,422 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $1,841,159 | 21,379 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $1,941,373 | 21,294 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $1,691,953 | 20,621 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $1,574,108 | 20,539 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $1,489,806 | 19,835 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $1,539,146 | 19,791 | Shares | Sole | 2021-07-09 | |
| 2021-03-31 | $1,525,689 | 19,791 | Shares | Sole | 2021-04-09 | |
| 2020-12-31 | $1,606,878 | 19,644 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $1,620,097 | 19,531 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $1,506,389 | 19,480 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $1,488,326 | 19,344 | Shares | Sole | 2020-04-07 | |
| No filing history on record for this holder in this stock. | ||||||